GASTROINTESTINAL STROMAL NEOPLASM
Clinical trials for GASTROINTESTINAL STROMAL NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new GASTROINTESTINAL STROMAL NEOPLASM trials appear
Sign up with your email to follow new studies for GASTROINTESTINAL STROMAL NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill combo aims to fight stubborn stomach tumors
Disease control Recruiting nowThis early-stage trial tests a new oral drug called ziftomenib combined with imatinib in adults with advanced gastrointestinal stromal tumors (GIST) that have stopped responding to imatinib alone. The study will enroll about 157 people to see if the combination is safe and can sh…
Matched conditions: GASTROINTESTINAL STROMAL NEOPLASM
Phase: PHASE1 • Sponsor: Kura Oncology, Inc. • Aim: Disease control
Last updated May 26, 2026 07:26 UTC
-
NIH launches Long-Term GIST study to unlock tumor secrets
Knowledge-focused Recruiting nowThis study follows 400 people with gastrointestinal stromal tumors (GISTs) to collect tumor tissue and blood samples for research. Participants are monitored every 6-12 months for up to 10 years before surgery, and then for 5 years after. The goal is to better understand the dise…
Matched conditions: GASTROINTESTINAL STROMAL NEOPLASM
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 14, 2026 12:05 UTC